Author

Amalia Feresiadou

Observed names: A. Feresiadou, Amalia Feresiadou Md

Institutions: Uppsala University, Uppsala University Hospital

Observed institutions: Uppsala University, Karolinska University Hospital, Uppsala University Hospital, Lund University, Sundsvall Municipality, Sahlgrenska University Hospital, Karolinska Institutet, Karlstad Central Hospital, Länssjukhuset Sundsvall-Härnösand, Skåne University Hospital, University of Gothenburg

OpenAlex ID: A5073802146

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

2022 · Fredrik Piehl, Ann Eriksson-Dufva, et al. · JAMA Neurology · 217

PDF

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

2018 · S. G. Berntsson, A. Kristoffersson, et al. · Acta Neurologica Scandinavica · 68

PDF

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort

2021 · Malin Petersson, Amalia Feresiadou, et al. · Neurology · 64

PDF

Autoimmune Encephalitis Presenting With Malignant Catatonia in a 40-Year-Old Male Patient With COVID-19

2021 · Jan Mulder, Amalia Feresiadou, et al. · American Journal of Psychiatry · 37

PDF

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab

2017 · Jan Fagius, Amalia Feresiadou, et al. · Multiple Sclerosis and Related Disorders · 36

Recurrence of Susac Syndrome following 23 Years of Remission

2014 · Amalia Feresiadou, Urban Eriksson, et al. · Case Reports in Neurology · 32

PDF

White matter abnormalities in a patient with visual snow syndrome: New evidence from a diffusion tensor imaging study

2021 · Francesco Latini, Markus Fahlström, et al. · European Journal of Neurology · 21

PDF

Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

2019 · Amalia Feresiadou, Kenneth Nilsson, et al. · Journal of Neuroimmunology · 19

Can diffusion tensor imaging (DTI) outperform standard magnetic resonance imaging (MRI) investigations in post-COVID-19 autoimmune encephalitis?

2022 · Francesco Latini, Markus Fahlström, et al. · Upsala Journal of Medical Sciences · 11

PDF

Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome

2023 · Domenico Plantone, Eleonora Sabatelli, et al. · European Journal of Neurology · 6

Rituximab in New‐Onset Generalized Myasthenia Gravis: Long‐Term Follow‐Up of the RINOMAX Clinical Trial

2025 · Jing Wu, Ann Eriksson‐Dufva, et al. · European Journal of Neurology · 5

PDF

Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid

2023 · Isa Lindqvist, Janet L. Cunningham, et al. · European Journal of Neurology · 4

PDF

Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis

2025 · Malin Petersson, Daniel Jons, et al. · Neurology · 2

Tubular aggregates in congenital myasthenic syndrome

2017 · Amalia Feresiadou, Olivera Casar-Borota, et al. · Neuromuscular Disorders · 2

Outside Back Cover

2018 · S. G. Berntsson, A. Kristoffersson, et al. · Acta Neurologica Scandinavica

PDF

Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

2015 · Jan Fagius, Joachim Burman, et al. · Multiple Sclerosis Journal

Works count: 17

Citation count: 524

H-index: 9

I10-index: 9